VAN ECK ASSOCIATES CORP - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 455 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 1.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
VAN ECK ASSOCIATES CORP ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$11,693
+5.5%
96,465
-0.3%
0.03%
+8.3%
Q2 2023$11,085
-13.0%
96,791
+4.7%
0.02%
-17.2%
Q1 2023$12,740
+5909.4%
92,434
+5556.9%
0.03%
+2800.0%
Q4 2022$212
-99.8%
1,634
+41.6%
0.00%
Q3 2022$128,000
-93.4%
1,154
-95.6%
0.00%
-100.0%
Q1 2021$1,953,000
-88.1%
26,209
-72.8%
0.01%
-89.6%
Q4 2020$16,424,000
-37.7%
96,335
-48.7%
0.05%
+14.3%
Q3 2020$26,372,000
-22.5%
187,792
-11.6%
0.04%
-28.8%
Q2 2020$34,044,000
+352.4%
212,328
+176.0%
0.06%
+55.3%
Q1 2020$7,526,000
-41.7%
76,934
-23.1%
0.04%
-24.0%
Q4 2019$12,909,000
+69.1%
100,038
-1.3%
0.05%
+38.9%
Q3 2019$7,634,000
-47.9%
101,352
+5.1%
0.04%
-49.3%
Q2 2019$14,654,000
-1.8%
96,440
-23.0%
0.07%
-2.7%
Q1 2019$14,927,000
+10.0%
125,235
+0.7%
0.07%
+7.4%
Q4 2018$13,568,000
-22.6%
124,325
+14.5%
0.07%
-20.9%
Q3 2018$17,534,000108,5620.09%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Sonic Fund II, L.P. 112,689$14,541,00014.93%
Casdin Capital, LLC 670,000$86,457,0007.95%
Logos Global Management LP 226,002$29,163,0007.19%
Avoro Capital Advisors LLC 1,760,000$227,110,0006.67%
Camber Capital Management LP 600,000$77,424,0003.94%
STANSBERRY ASSET MANAGEMENT, LLC 71,133$9,179,0003.74%
Eventide Asset Management 996,000$128,524,0003.62%
CADIAN CAPITAL MANAGEMENT, LP 550,000$70,972,0003.14%
RTW INVESTMENTS, LP 605,762$78,168,0002.95%
Consonance Capital Management LP 356,145$45,957,0002.80%
View complete list of SAREPTA THERAPEUTICS INC shareholders